UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING...
ULURU Inc. Announces Approval to Market Altrazeal® in New Zealand - Near Term Altrazeal® to be Launched in Six Markets - - Approval to Market in...
ULURU Inc. Announces Intention to Transition From NYSE Amex to OTC Markets PR Newswire ADDISON, Texas, March 12, 2012 ADDISON, Texas, March 12...
ULURU Inc. Announces Approval to Market Altrazeal® in Australia - Altrazeal® Launch Anticipated in Second Quarter 2012 - PR Newswire ADDISON...
As filed with the Securities and Exchange Commission on February 14, 2012 Registration Number 333-_____ _______________________________...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE...
ULURU Inc. Receives Notice From NYSE Amex Regarding Continued Listing Standards PR Newswire ADDISON, Texas, Feb. 7, 2012 ADDISON, Texas, Feb. 7...
ULURU Inc. Extends the European Altrazeal® License to Include the Middle East and Africa PR Newswire ADDISON, Texas, Jan. 17, 2012 ADDISON...
ULURU Inc. Extends the European Altrazeal® License to Include Australia and New Zealand - Registration Anticipated in the First Quarter 2012...
ULURU Inc. Receives Notice From NYSE Amex Regarding Continued Listing Standards PR Newswire ADDISON, Texas, Dec. 9, 2011 ADDISON, Texas...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.